false
0001849380
0001849380
2026-11-06
2026-11-06
0001849380
ONMD:CommonStock0.0001ParValuePerShareMember
2026-11-06
2026-11-06
0001849380
ONMD:RedeemableWarrantsEachLotOf10WarrantsIsExercisableForOneShareOfCommonStockAtExercisePriceOf115.00PerShareMember
2026-11-06
2026-11-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2026
ONEMEDNET
CORPORATION
(Exact
name of Registrant as Specified in Its Charter)
| Delaware | | 001-40386 |
|
86-2076743 |
(State
or Other Jurisdiction
of Incorporation) | | (Commission
File
Number) |
|
(IRS
Employer
Identification No.) |
6385 Old Shady Oak Road, Suite 250
Eden Prairie, MN 55344
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, Including Area Code: 800-918-7189
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on which registered |
| Common
Stock, $0.0001 par value per share |
|
ONMD |
|
The
Nasdaq Stock Market LLC |
| |
|
|
|
|
| Redeemable
Warrants, each lot of 10 warrants is exercisable for one share of Common Stock at an exercise price of $115.00 per share |
|
ONMDW |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item
2.02 | Results
of Operations and Financial Condition. |
On
November 6, 2026, OneMedNet Corporation issued a press release announcing preliminary financial information for quarter ended September
30, 2026 and financial guidance for the fourth quarter of 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current
Report on Form 8-K.
The
information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference
in such filing.
| Item
9.01. | Financial
Statements and Exhibits. |
(d)
Exhibits.
| Exhibit
No. |
|
Description |
| 99.1 |
|
Press Release dated November 6, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded as Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
November 6, 2026
| |
ONEMEDNET
CORPORATION |
| |
|
|
| |
By:
|
/s/
Aaron Green |
| |
|
Aaron
Green |
| |
|
Chief
Executive Officer |
Exhibit
99.1
FOR
IMMEDIATE RELEASE
OneMedNet
Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook
MINNEAPOLIS,
NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,”
“we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade,
AI-driven Real-World Data (RWD), today announced preliminary revenue results for the third quarter ended September 30, 2026, and provides
revenue guidance for the fourth quarter of 2026.
The
Company expects to report revenue of approximately $1 million for the quarter ended September 30, 2026, representing a 242% increase
from the prior quarter ended June 30, 2026, and a 465% increase from the prior-year quarter ended September 30, 2025. The Company also
forecasts revenue of approximately $12 million to $14 million for the fourth quarter of 2026, pending the anticipated acceptance of delivered
data by customers.
OneMedNet’s
sales funnel has grown substantially over the course of 2026, and the Company began delivering on that funnel at scale during the third
quarter of 2026. Consistent with order timing combined with scaled delivery, 2026 revenue is weighted to occur at a faster pace in the
fourth quarter of 2026.
Our
financial momentum reflects the Company’s First-Party (Direct-from-Source) multi-modal data sourced directly from its healthcare
provider partners, not intermediaries or secondary markets, and the scaling of its de-Identified pipeline and delivery infrastructure,
which de-identifies each study at the source while preserving the diagnostic fidelity its customers require.
“Our
sales funnel has grown substantially this year, and we are now delivering on it,” said Aaron Green, President & CEO of OneMedNet.
“The hardest work in this business; curating, de-identifying, and delivering regulatory-grade multimodal data at scale, is substantially
complete. We are now able to get our product in our customers’ hands with the ability to convert the sales to revenue. Our anticipated
revenue pace in the fourth quarter of 2026 is expected for two reasons: our data coming direct from our healthcare provider partners,
and our building of our de-identification pipeline and delivery infrastructure to scale with demand. “
Third
Quarter Preliminary Revenue and Fourth Quarter Outlook Highlights
| ● | Preliminary
third quarter 2026 revenue of approximately $1 million. Consistent with previously communicated
delivery timing. |
| ● | Fourth
quarter 2026 revenue guidance of approximately of $12 million to $14 million, pending
anticipated customer acceptance of delivered data by quarter-end. |
Third
quarter 2026 revenue results are preliminary and are subject to finalization and adjustment in connection with the preparation of the
Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, which we expect to release by November 16, 2026.
About
OneMedNet Corporation
OneMedNet
Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready
datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300
sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device
manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform supports
applications ranging from drug development and regulatory submissions to foundational AI model training.
Learn
more at www.onemednet.com.
Forward-Looking
Statements
This
press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press
release are forward-looking statements. These statements include, but are not limited to, statements regarding our preliminary results
for third of 2026, our revenue outlook for the fourth quarter of 2026, the timing of revenue recognition, the anticipation of data delivery
and customer acceptance, and statements generally about our products, plans and strategies.
Forward-looking
statements are based on information available at the time those statements are made and were based on current expectations as well as
the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties,
many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include but are not limited
to our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive
environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual
Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake
any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments,
or otherwise.
OneMedNet
Contacts:
Michael
Wong, VP Marketing
Email:
michael.wong@onemednet.com
SOURCE:
ONEMEDNET CORPORATION
